Treatment of non-metastatic castration-resistant prostate cancer: focus on apalutamide

Anita Gul,1 Jorge A Garcia,1 Pedro C Barata21Department of Hematology/Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA; 2Tulane University, New Orleans, LA, USAAbstract: Androgen deprivation therapy (ADT) is an important component of systemic therapy in advanced prosta...

Full description

Bibliographic Details
Main Authors: Gul A, Garcia JA, Barata PC
Format: Article
Language:English
Published: Dove Medical Press 2019-08-01
Series:Cancer Management and Research
Subjects:
Online Access:https://www.dovepress.com/treatment-of-non-metastatic-castration-resistant-prostate-cancer-focus-peer-reviewed-article-CMAR